news, journals and articles from all over the world.
University of Kentucky College of Medicine researchers are using special antibodies made by alpacas to help understand COVID-19 and potentially develop a treatment that could protect people from being infected.
Read more
A technology spun from carbon nanotube sensors discovered 20 years ago by Lawrence Berkeley National Laboratory (Berkeley Lab) scientists could one day help healthcare providers test patients for COVID-19, the disease caused by the coronavirus SARS-CoV-2.
Read more
Preliminary results from a scientific study aimed at measuring the spread of the novel coronavirus in Indiana show a general population prevalence of about 2.8 percent of the state’s population.
Read more
University of Kentucky researchers have launched antibody testing that will help to understand what immunity to COVID-19 really means.
Read more
Joe G. N. “Skip” Garcia, MD, an academic pulmonary physician-scientist describes a complication in COVID-19.
Read more
Lawrence Livermore National Laboratory researchers have identified an initial set of therapeutic antibody sequences, designed in a few weeks using machine learning and supercomputing, aimed at binding and neutralizing SARS-CoV-2, the virus that causes COVID-19. The research team is performing experimental testing on the chosen antibody designs.
Read more
Montefiore Health System, Albert Einstein College of Medicine and NYU Langone have launched a new clinical trial to study if convalescent plasma—taken from people who have recovered from COVID-19—is effective in treating the disease.
Read more
The Indiana University Richard M. Fairbanks School of Public Health at IUPUI is collaborating with the state health department to conduct a scientific study to measure the spread of COVID-19 throughout Indiana.
Read more
Physicians and scientists at UC San Diego Health have launched a pair of serological tests that will look for novel coronavirus antibodies—evidence in persons tested that they have previously been infected by the viral cause of COVID-19, even if they never experienced tell-tale symptoms.
Read moreAs scientists forge ahead to piece together a comprehensive profile of the new coronavirus fueling a historic pandemic, they are focusing their efforts on six areas: epidemiology, diagnostics, pathogenesis, clinical disease management, treatment and vaccines.
Read more
Using a research assay called VirScan, scientists plan to study how antibodies from people who have had COVID-19 attack the virus that causes it.
Read more